We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-1.69%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$544B
AUM Growth
+$2.89B
Cap. Flow
+$24.2B
Cap. Flow %
4.45%
Top 10 Hldgs %
14.36%
Holding
11,092
New
1,200
Increased
4,608
Reduced
3,996
Closed
929

Top Sells

Rank Stock Value
1
MSTR icon
Strategy Inc
MSTR
+$726M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$562M
3
MSFT icon
Microsoft
MSFT
+$557M
4
PSX icon
Phillips 66
PSX
+$548M
5
BA icon
Boeing
BA
+$465M

Sector Composition

Rank Sector Weight
1 Technology 16.49%
2 Financials 10%
3 Healthcare 7.03%
4 Consumer Discretionary 6.75%
5 Industrials 6.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMSI icon
8426
Smith Micro Software
SMSI
$14.5M
$13.4K ﹤0.01%
3,667
+3,619
+7,540% +$21.8K
NVAWW
8427
DELISTED
Nova Minerals Ltd Warrant
NVAWW
$13.4K ﹤0.01%
3,445
-403
-10% -$2.29K
NVOH
8428
Novo Nordisk A/S (B Shares) ADRhedged
NVOH
$5.08M
$13.4K ﹤0.01%
+335
New +$16.1K
ACTU
8429
Actuate Therapeutics
ACTU
$26.6M
$13.4K ﹤0.01%
1,979
+45
+2% +$361
IROHR
8430
DELISTED
Iron Horse Acquisitions Corp Right
IROHR
$13.4K ﹤0.01%
+44,574
New +$13.1K
HBIO icon
8431
Harvard Bioscience
HBIO
$27.5M
$13.3K ﹤0.01%
2,357
-1,360
-37% -$17.4K
EZRA
8432
Reliance Global Group
EZRA
$1.49M
$13.3K ﹤0.01%
280
-804
-74% -$56.3K
OCEA
8433
DELISTED
Ocean Biomedical, Inc. Common Stock
OCEA
$13.3K ﹤0.01%
246,259
+191,112
+347% +$45.7K
NE.WS.A icon
8434
Noble Corporation PLC Tranche 2 Warrants
NE.WS.A
$13.3K ﹤0.01%
2,705
-39
-1% -$370
TURN
8435
DELISTED
180 Degree Capital
TURN
$13.3K ﹤0.01%
3,338
+305
+10% +$1.19K
ENGNW icon
8436
enGene Therapeutics Warrants
ENGNW
$3.02M
$13.2K ﹤0.01%
21,933
+19,106
+676% +$15.7K
SXTC icon
8437
China SXT Pharmaceuticals
SXTC
$2.36M
$13.1K ﹤0.01%
+35
New +$18.2K
HSPOU
8438
DELISTED
Horizon Space Acquisition I Corp Unit
HSPOU
$13.1K ﹤0.01%
+1,176
New +$14K
USOI icon
8439
Credit Suisse AG Credit Suisse X-Links Crude Oil Shares Covered Call ETN
USOI
$41.5M
$13K ﹤0.01%
212
+108
+104% +$6.8K
TXS icon
8440
Texas Capital Texas Equity Index ETF
TXS
$38M
$13K ﹤0.01%
+414
New +$13.5K
HWM icon
8441
PUT
Howmet Aerospace
HWM
$113B
$13K ﹤0.01%
100
DUG icon
8442
ProShares UltraShort Energy
DUG
$20.6M
$13K ﹤0.01%
383
-484
-56% -$18K
THNR
8443
Amplify Weight Loss Drug & Treatment ETF
THNR
$5.08M
$12.9K ﹤0.01%
598
+152
+34% +$3.46K
LGHL
8444
Lion Group Holding
LGHL
$853K
$12.8K ﹤0.01%
+34
New +$27.3K
WGRX
8445
DELISTED
Wellgistics Health
WGRX
$12.8K ﹤0.01%
+59
New +$9.95K
PINK icon
8446
Simplify Health Care ETF
PINK
$375M
$12.8K ﹤0.01%
435
-7,139
-94% -$214K
WOK
8447
WORK Medical Technology Group
WOK
$4.76M
0
CAMP icon
8448
CAMP4 Therapeutics
CAMP
$179M
$12.7K ﹤0.01%
3,183
-7,125
-69% -$34.5K
EUDV icon
8449
ProShares MSCI Europe Dividend Growers ETF
EUDV
$8.36M
$12.7K ﹤0.01%
257
-32
-11% -$1.57K
MOVE icon
8450
Corvex Inc
MOVE
$299M
$12.7K ﹤0.01%
939
-307
-25% -$9.8K

Similar funds

UBS Group's Q1 2025 Portfolio in Review

As of Q1 2025, UBS Group held 11,092 positions worth $544B, up 0.53% from $541B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS Group deployed $24.2B of net new capital in Q1 2025, opening 1,200 new positions and adding to 4,608 existing holdings. Its largest new stake was Sandisk: 3,424,800 shares worth $163M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Strategy Inc, an estimated $726M trimmed.

  • UBS Group's largest Q1 2025 buy was Sandisk: 3,424,800 shares worth $163M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $1.64B increase.
  • UBS Group's biggest Q1 2025 reduction was Strategy Inc, cutting an estimated $726M.
  • UBS Group fully exited Smartsheet Inc. in Q1 2025, selling an estimated $432M.
  • UBS Group's ten largest holdings make up 14% of its $544B portfolio in Q1 2025.
  • UBS Group opened 1,200 new positions and closed 929 in Q1 2025.
  • UBS Group's portfolio value rose 0.53% quarter-over-quarter to $544B.

Based on UBS Group's 13F filing for Q1 2025, filed 13 May 2025.